Why Valeant Pharmaceuticals Intl Inc. Shares Surged as Much as 17% on Monday

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares soared after the company announced Michael Pearson will be stepping down.

| More on:
The Motley Fool

On March 21, there were more developments in the Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) saga.

Most notably, the company announced that CEO Michael Pearson will be stepping down as soon as a successor is found. In addition, activist investor Bill Ackman, head of Pershing Square Capital Management, has now joined the board of directors. And to top it all off, Valeant blamed its past financial misstatements on former CFO Howard Schiller and asked him to resign from the board of directors. Yet he has refused to do so.

While these developments may look like signs of chaos, investors reacted warmly to the news, sending Valeant’s shares up by as much as 17%. So why exactly did Valeant’s shares increase, and what does this news mean for the company in the long term?

Michael Pearson’s departure

Michael Pearson has been the face of Valeant’s rise as well as its fall. It was he who moved the company from the United States to Canada primarily for tax reasons. It was he who slashed Valeant’s R&D spending in favour of an acquisition-based model. And as the company finds itself in a downward spiral, he is at the centre of it all.

Up until March he was still held in very high regard. When the Philidor story dominated headlines, Mr. Ackman reiterated his support for Mr. Pearson. Then when Mr. Pearson had to step down at the end of 2015 (for health-related reasons), Valeant’s share price fell. More recently, Nomura Securities analyst Shibani Malhotra said Valeant would lose its competitive advantage if Mr. Pearson stepped down.

But that all changed when Valeant lowered its 2016 guidance on March 14. Now there’s a sense that the company has no idea what it’s doing, which, of course, reflects badly on the CEO. So it’s no surprise that his departure is being received well.

Bill Ackman’s presence

Not unlike Mr. Pearson, Bill Ackman is another public figure whose reputation has taken a dramatic turn for the worse.

Long known as one of Wall Street’s best activist investors, Mr. Ackman has had some remarkable successes; for example, he initiated the turnaround at Canadian Pacific Railway Limited, which has been a tremendous win for shareholders of that company.

But more recently, the story has been very different. When Valeant started running into trouble, he increased his stake, saying his biggest regret was that he wasn’t in a position to buy more shares. He also said that the company’s biggest problem was poor communication. During a conference call, he even predicted that Valeant’s shares would reach US$448 by 2019.

Yet Mr. Ackman still is held in high regard, so his decision to join the board may be viewed as a small positive.

Howard Schiller

It may seem unfair that Mr. Schiller is being made the scapegoat, since he stepped in as interim-CEO during a very difficult time. Then again, he was CFO at a time when the company misstated its financials.

In any case, this controversy is really more of a side story. Mr. Pearson’s departure was certainly the main reason Valeant’s share price increased, and Mr. Ackman’s increased involvement was likely a factor as well. We’ll have to wait and see how this all plays out.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Trans Alaska Pipeline with Autumn Colors
Energy Stocks

If Growth Is Your Game, We Have the Name of the Dividend Stock for You

Enbridge (TSX:ENB) might be a great buy for one's TFSA in the new year.

Read more »

dividend growth for passive income
Dividend Stocks

Forget GICs! These Dividend Stocks Are a Far Better Buy

CT REIT (TSX:CRT.UN) and another dividend that might be worth considering if you're fed up with low rates on GICs.

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Dividend Stocks

Don’t Bet Against Canada’s Top Dividend Icons Going Into the New Year

Brookfield Renewable Partners (TSX:BEP.UN) and another renewable dividend icon that might be worth picking up.

Read more »

voice-recognition-talking-to-a-smartphone
Dividend Stocks

Sure, Telus Paused Its Payout: It’s My Newest Top Stock Pick

Telus (TSX:T) stock might be closer to a bottom than the top. Here are reasons why it's worth checking out…

Read more »

Concept of multiple streams of income
Dividend Stocks

2 Spin-off Stocks Poised to Outperform in the New Year and Beyond

Two spin-off stocks could outperform in 2026 and beyond because of their focused operations and distinct growth paths.

Read more »

stocks climbing green bull market
Stocks for Beginners

This Dividend Stock is Set to Beat the TSX Again and Again

Dividend investors may be overlooking TD’s boring strength, and that slump could be today’s best entry point.

Read more »

a person prepares to fight by taping their knuckles
Investing

Is Dollarama or Waste Connections a Better Defensive Stock in 2026?

Let’s compare these two stocks to find out which one offers the stronger defensive investment opportunity this year.

Read more »

Canadian dollars in a magnifying glass
Bank Stocks

1 Dividend Stock I’ll Be Checking in On Closely in 2026

TD Bank (TSX:TD) stock had a year for the record books, but shares are not yet overpriced.

Read more »